Hayes, Inc. Slide Presentation

This is a slide presentation of a webinar presented on March 6, 2014.

Slide 1

Hayes, Inc. Knowledge Transfer Contractor

Hayes, Inc.Knowledge Transfer Contractor

Cici Collins

  • VP Government Contracting.

Susan Levine, MS, DVM, PhD

  • Project Director.

Karen Crotty, PhD, MPH

  • Project Manager.

Slide 2

About Hayes

About Hayes

Hayes, Inc. was founded 25 years ago to provide objective, independent, evidence-based assessments as the foundation for decisions about coverage, acquisition, and use of medical tests, treatments, and preventive programs.

We are a woman-owned small business that operates with a primarily distributed workforce of 55 staff.

Slide 3

Our Clients

Our Clients

  • Health plans.
  • Hospitals and health systems.
  • State Medicaid Agencies.
  • TRICARE.
  • VA Health Administration Center.

No conflicts of interest

Slide 4

Current KT Task Orders

Current KT Task Orders

Implementing AHRQ Tools for Nurses to Improve Quality of Care (KT-FY13-05)

Continuing Education for Comparative Effectiveness Research (KT-FY13-02)

Slide 5

Importance of Knowledge Transfer

Importance of Knowledge Transfer

We believe strongly that the appropriate use of evidence is a critical factor in improving the safety, quality, and value of healthcare and that knowledge transfer is key to ensuring that evidence is understood and used.

We believe that knowledge transfer includes all steps between the creation of new knowledge and its application.

Slide 6

Knowledge Transfer

Knowledge Transfer

Image of a chart showing the knowledge transfer process.

Slide 7

Our Expertise

Our Expertise

Gathering relevant knowledge

  • Literature searches.
  • Environmental scans.
  • Horizon scans.
  • Gray literature sources.
  • Clinical trials databases.
  • Regulatory information.

Synthesizing research evidence

  • Systematic reviews.
  • Comparative effectiveness reviews.
  • Health technology assessments.
  • Rapid reviews.

Slide 8

Our Expertise

Our Expertise

Translating evidence

  • Reports.
  • Graphics.
  • Algorithms/clinical pathways/clinical guidelines.
  • Coverage policies.
  • Learning modules.

Disseminating knowledge

  • Live webinars.
  • In-person presentations and workshops.
  • On-site 'embedded' personnel.
  • Training materials/continuing medical education (CME) activities.

Slide 9

Medicaid Agency: Identify Evidence-Based Interventions Most Likely to Improve Pregnancy Outcomes in a Medicaid Population

Medicaid Agency: Identify Evidence-Based Interventions Most Likely to Improve Pregnancy Outcomes in a Medicaid Population

Stakeholders

  • Medicaid beneficiaries.
  • Medicaid providers.
  • State Medicaid Agency.
  • Experts in maternal and child health.

Slide 10

Evidence-Based Interventions to Improve Pregnancy Outcomes

Evidence-Based Interventions to Improve Pregnancy Outcomes

Gather Research Evidence

Phase 1. Epidemiological, historical, and survey data about causes of poor pregnancy outcomes, with additional limit to modifiable causes.

Phase 2. Clinical trial and observational evidence about effectiveness of interventions to reduce risk of preterm birth.

Synthesize Evidence

Phase 1. Identification of preterm birth as the leading modifiable cause of poor pregnancy outcome.

Phase 2. Identification of causes of preterm birth and effective interventions for reducing risk of preterm birth.

Translate Evidence

Three evidence-based interventions: Screening for and treatment of short cervix; smoking cessation; family planning.

Slide 11

Evidence-Based Interventions to Improve Pregnancy Outcomes

Evidence-Based Interventions to Improve Pregnancy Outcomes

Disseminate

Concise white paper describing interventions and rationale, distributed to state Medicaid Agency and to Expert Panel on Improving Maternal and Infant Outcomes in Medicaid and Children's Health Insurance Program (CHIP).

Apply

Policy development; implementation of quality measures for Medicaid providers based on evidence-based interventions.

Impact

Budget allocation for provider training and program implementation; improved access to care, improved and more consistent quality of care for Medicaid recipients; better pregnancy outcomes [projected].

Slide 12

Develop Evidence-Based Clinical Pathway for Assessment, Diagnosis, and Treatment of Community-Acquired Pneumonia in Primary Care Setting

Develop Evidence-Based Clinical Pathway for Assessment, Diagnosis, and Treatment of Community-Acquired Pneumonia in Primary Care Setting

Stakeholders

  • Physician-led Accountable Care Organization (ACO) Administration
  • ACO Clinical Committee members
  • Network providers
  • Patients

Slide 13

Evidence-Based Clinical Pathway for Community-Acquired Pneumonia

Evidence-Based Clinical Pathway for Community-Acquired Pneumonia

Gather Research Evidence

Evidence-based clinical assessment tools, diagnostic algorithms, current therapeutic guidelines.

Synthesize Evidence

Extract key elements of clinical assessment tools, diagnostic pathways, and guidelines for treatment of community-acquired pneumonia in primary care practice.

Translate Evidence

Clinical pathways for management of adults and children with community-acquired pneumonia designed for use in primary care.

Slide 14

Evidence-Based Clinical Pathway for Community-Acquired Pneumo

Evidence-Based Clinical Pathway for Community-Acquired Pneumonia

Disseminate

Clinical pathways sent to ACO Clinical Committee and then disseminated as web-based documents to primary care provider network (~1500 providers) with link to ACO pharmacy to ensure alignment of prescribed drugs with current formulary.

Apply

Adherence to pathways will be used as a quality measure for providers in network.

Impact

Improve quality and consistency of primary care; avoid potential morbidity associated with hospitalization; reduce cost of care.

Slide 15

Public Payer (State): Systematic Review of Bilateral Versus Unilateral Cochlear Implants in Children and Adults

Public Payer (State): Systematic Review of Bilateral Versus Unilateral Cochlear Implants in Children and Adults

Stakeholders

  • Department of Social and Health Services (Medicaid).
  • Department of Labor and Industries.
  • Department of Corrections.
  • Department of Veterans Affairs.
  • Healthcare providers.
  • Beneficiaries covered under state health plans.
  • Taxpayers.

Slide 16

Systematic Review of Bilateral Versus Unilateral Cochlear Implants in Children and Adults

Systematic Review of Bilateral Versus Unilateral Cochlear Implants in Children and Adults

Gather Research Evidence

Existing systematic reviews and meta-analyses; primary studies not included in existing reviews.

Synthesize Evidence

Balance of benefits and harms for patient-important outcomes; considered within context of quality of the evidence.

Translate Evidence

Written report, including concise summary; accompanying PowerPoint summary, utilizing graphical representation of key findings.

Slide 17

Systematic Review of Bilateral Versus Unilateral Cochlear Implants in Children and Adults

Systematic Review of Bilateral Versus Unilateral Cochlear Implants in Children and Adults

Disseminate

Presentation of findings to Clinical Committee in an open forum, with opportunity for public comment and written response to comments; full report and summary posted on public website.

Apply

Coverage policy developed at conclusion of presentation: Bilateral cochlear implants are a covered benefit for adults and children ≥ 12 months of age.

Impact

Improved access to care and consistency of care among populations served by the state healthcare authority.

Slide 18

Live CE Webinar Series

Live CE Webinar Series

Stakeholders

  • Physicians.
  • Nurse practitioners and other advanced practice nurses.
  • Registered nurses.
  • Case managers.
  • Healthcare executives and administrators.
  • Value analysis specialists.
  • Nurse and patient educators.
  • Physical therapists.
  • Pharmacists.
  • Psychologists.
  • Genetic counselors.

Slide 19

CE Webinars

CE Webinars

Gather Research Evidence

Best available clinical studies; varies depending on technology, intervention, or program being addressed.

Synthesize Evidence

Conclusions regarding safety, efficacy, comparative effectiveness of technology/intervention.

Translate Evidence

Summary tables, graphics to illustrate findings, videos and animations, Hayes Rating.

Slide 20

CE Webinars

CE Webinars

Disseminate

Live and recorded webinar presentations, handouts and notes with additional information, question-and-answer session.

Apply

Learners share knowledge with peers, staff, patients; critically appraise research findings and apply evidence-based approach to decision making; change clinical practice.

Impact

65 programs in past 3 years, with a total of 7303 attendees.

Slide 21

Collaborations

Collaborations

  • Global Prairie Marketing, LLC
    • IDIQ subcontractor.
    • CE for CER Task Order.
  • Deloitte Consulting, LLP
    • IDIQ subcontractor.
    • CE for CER Task Order.
  • JumpStart Healthcare Communications, LLC
    • IDIQ subcontractor.

Slide 22

Knowledge Transfer

Knowledge Transfer

Image of a flowchart showing the knowledge transfer process.

Page last reviewed March 2014
Internet Citation: Hayes, Inc. Slide Presentation. March 2014. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/cpi/centers/ockt/kt/webinars/ktidiq/hayesslides.html